
Lorraine Spector
Examiner (ID: 17600, Phone: (571)272-0893 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, STIC, 1646, 1812 |
| Total Applications | 788 |
| Issued Applications | 338 |
| Pending Applications | 71 |
| Abandoned Applications | 379 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5936005
[patent_doc_number] => 20020061557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Glycoprotein hormone receptor molecules'
[patent_app_type] => new
[patent_app_number] => 09/877804
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28493
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061557.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877804 | Glycoprotein hormone receptor molecules | Jun 6, 2001 | Abandoned |
Array
(
[id] => 6656660
[patent_doc_number] => 20030077756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Identification and modification of immunodominant epitopes in polypeptides'
[patent_app_type] => new
[patent_app_number] => 09/872702
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19665
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077756.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872702 | Identification and modification of immunodominant epitopes in polypeptides | May 31, 2001 | Issued |
Array
(
[id] => 6711115
[patent_doc_number] => 20030170864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/866034
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 60517
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170864.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866034 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 24, 2001 | Abandoned |
Array
(
[id] => 6560256
[patent_doc_number] => 20020164687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Platelet-derived growth factor C, DNA coding therefor, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/852209
[patent_app_country] => US
[patent_app_date] => 2001-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 20747
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164687.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852209 | Platelet-derived growth factor C, DNA coding therefor, and uses thereof | May 9, 2001 | Abandoned |
Array
(
[id] => 1587466
[patent_doc_number] => 06482407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-19
[patent_title] => 'Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same'
[patent_app_type] => B2
[patent_app_number] => 09/847185
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 16140
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482407.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847185
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847185 | Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same | Apr 30, 2001 | Issued |
Array
(
[id] => 6326689
[patent_doc_number] => 20020197681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Identification and uses of a hyaluronan receptor for endocytosis'
[patent_app_type] => new
[patent_app_number] => 09/842930
[patent_app_country] => US
[patent_app_date] => 2001-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 29269
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842930
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842930 | Hyaluronan receptor for endocytosis | Apr 24, 2001 | Issued |
| 09/837970 | Seven transmembrane receptor (AXOR57) | Apr 18, 2001 | Abandoned |
Array
(
[id] => 1415020
[patent_doc_number] => 06506362
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-14
[patent_title] => 'Labeled compounds that bind to a thrombopoietin receptor'
[patent_app_type] => B1
[patent_app_number] => 09/832230
[patent_app_country] => US
[patent_app_date] => 2001-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 41
[patent_no_of_words] => 33707
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506362.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832230
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832230 | Labeled compounds that bind to a thrombopoietin receptor | Apr 9, 2001 | Issued |
Array
(
[id] => 6716403
[patent_doc_number] => 20030027751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'VEGF fusion proteins'
[patent_app_type] => new
[patent_app_number] => 09/832355
[patent_app_country] => US
[patent_app_date] => 2001-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43628
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832355
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832355 | VEGF fusion proteins | Apr 9, 2001 | Abandoned |
Array
(
[id] => 1220739
[patent_doc_number] => 06703360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-09
[patent_title] => 'Compositions and methods related to canine IgG and canine IL-13 receptors'
[patent_app_type] => B2
[patent_app_number] => 09/828995
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51047
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703360.pdf
[firstpage_image] =>[orig_patent_app_number] => 09828995
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/828995 | Compositions and methods related to canine IgG and canine IL-13 receptors | Apr 8, 2001 | Issued |
Array
(
[id] => 6614134
[patent_doc_number] => 20020015981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Beta-like glycoprotein hormone polypeptide and heterodimer'
[patent_app_type] => new
[patent_app_number] => 09/818954
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38062
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015981.pdf
[firstpage_image] =>[orig_patent_app_number] => 09818954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/818954 | Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof | Mar 26, 2001 | Issued |
| 09/720285 | NR8 NUCLEIC ACIDS, POLYPEPTIDES, AND VARIANTS AND USES THEREOF | Mar 22, 2001 | Abandoned |
Array
(
[id] => 6048994
[patent_doc_number] => 20020169292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Cystine knot growth factor mutants'
[patent_app_type] => new
[patent_app_number] => 09/813398
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 117758
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813398
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813398 | Cystine knot growth factor mutants | Mar 19, 2001 | Abandoned |
Array
(
[id] => 6846640
[patent_doc_number] => 20030165807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING CORTICOTROPIN RELEASING FACTOR RECEPTORS'
[patent_app_type] => new
[patent_app_number] => 09/799978
[patent_app_country] => US
[patent_app_date] => 2001-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22296
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09799978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/799978 | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors | Mar 5, 2001 | Issued |
Array
(
[id] => 5904998
[patent_doc_number] => 20020141970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Stable aqueous solutions of granulocyte macrophage colony-stimulating factor'
[patent_app_type] => new
[patent_app_number] => 09/800016
[patent_app_country] => US
[patent_app_date] => 2001-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5308
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20020141970.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800016
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800016 | Stable aqueous solutions of granulocyte macrophage colony-stimulating factor | Mar 4, 2001 | Abandoned |
Array
(
[id] => 7000423
[patent_doc_number] => 20010053536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor'
[patent_app_type] => new
[patent_app_number] => 09/795333
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9114
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053536.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795333
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795333 | cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6617286
[patent_doc_number] => 20020064855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Genes that regulate hematopoietic blood forming stem cells and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/789919
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 37342
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064855.pdf
[firstpage_image] =>[orig_patent_app_number] => 09789919
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/789919 | Genes that regulate hematopoietic blood forming stem cells and uses thereof | Feb 20, 2001 | Abandoned |
Array
(
[id] => 6846876
[patent_doc_number] => 20030166043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Human tubby homolog'
[patent_app_type] => new
[patent_app_number] => 09/782390
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17246
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166043.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782390
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782390 | Human tubby homolog | Feb 11, 2001 | Abandoned |
Array
(
[id] => 6433107
[patent_doc_number] => 20020127652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Follicle stimulating hormones'
[patent_app_type] => new
[patent_app_number] => 09/780933
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25516
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127652.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780933
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780933 | Follicle stimulating hormones | Feb 8, 2001 | Abandoned |
Array
(
[id] => 5828542
[patent_doc_number] => 20020068342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Novel nucleic acid and amino acid sequences and novel variants of alternative splicing'
[patent_app_type] => new
[patent_app_number] => 09/778927
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 113
[patent_figures_cnt] => 113
[patent_no_of_words] => 20706
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068342.pdf
[firstpage_image] =>[orig_patent_app_number] => 09778927
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/778927 | Novel nucleic acid and amino acid sequences and novel variants of alternative splicing | Feb 7, 2001 | Abandoned |